Sodium cromoglicate + ibuprofen combination regimen - AZTherapies

Drug Profile

Sodium cromoglicate + ibuprofen combination regimen - AZTherapies

Alternative Names: ALZT OP1; ALZTOP1a + ALZTOP1b; Ibuprofen + cromolyn; Ibuprofen + sodium cromoglicate

Latest Information Update: 21 Sep 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator AZTherapies
  • Class Antiallergics; Benzopyrans; Chromones; Phenylpropionates; Small molecules
  • Mechanism of Action Amyloid beta-protein inhibitors; Inflammation mediator inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Alzheimer's disease

Most Recent Events

  • 15 Sep 2015 AZTherapies receives Special Protocol Assessment agreement for a pivotal phase III trial in Alzheimer's disease from US FDA
  • 15 Sep 2015 AZTherapies plans a phase III trial in Alzheimer's disease in USA and other countries
  • 13 Aug 2015 Phase-III clinical trials in Alzheimer's disease (Early-stage disease) in Australia (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top